And now for something completely different
We take a look at a trust which could add significant diversification to income investors’ portfolios…
Further cancer breakthroughs hinge on biotech investment
By Marek Poszepczynski and Ailsa Craig, co-investment managers of the International Biotechnology Trust...
Slides and Audio: International Biotechnology Trust
Download the presentation and listen to the audio from our 'Ideas for your ISA' Spring Conference on 03 March...
Is biotechnology M&A the big opportunity post-vaccine?
After a vintage year in which healthcare stocks were at the forefront of addressing the coronavirus pandemic, a wave of M&A in the sector promises opportunities for investors…
Income, growth, diversification: A compelling combination
This trust offers a blend of characteristics which might appeal to many investors...
M&A and unlisted companies: Two powerful themes behind International Biotechnology Trust
The acquisition of smaller biotech companies by their larger counterparts has been a tailwind for investors in this high-octane sector...
Biotech: The high stakes investment theme where expertise is everything
We meet the team of doctors and medical scientists behind International Biotechnology Trust...
IBT offers a differentiated exposure to a secular growth theme complemented by a solid yield…
The trends powering biotech for decades to come
At a time when healthcare is in the headlines, we take a look at the longer-term trends that are driving biotechnology innovation on a global scale...
Results analysis: International Biotechnology Trust
International Biotechnology Trust (IBT) released its interim results this week, amid a rapidly changing landscape for the healthcare sector...